InvestorsHub Logo
Followers 38
Posts 2912
Boards Moderated 0
Alias Born 06/05/2012

Re: Luckytouch post# 383912

Friday, 11/12/2021 4:05:30 PM

Friday, November 12, 2021 4:05:30 PM

Post# of 402939
This! These could be the same kind of small trials that resulted in the deal with AlfaSigma.

Luckytouch said,

DeGrado could give input on other indications for treatments maybe with Asthma or COPD (PDE4 and anti-inflammatory) via nebulizer. Could be done as POC P1/2 in hospital or by pulmonologist in out patient setting. Doseing determined inP1 and nebulized with an in line set with O2. That could be a low cost trial yielding lots of data and validating B via nebulizer and opening the door to Covid at early stage and competitive with the announced orals by Merk/Ridgemont and Pfizer. We can’t just roll over now. Leo is good at scrambling and surviving and this is a big challenge.


"It is difficult to get a man to understand something, when his salary depends upon his not understanding it."

Upton Sinclair

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News